{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:41:48Z","timestamp":1791236508870,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00603-3","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:11:45Z","timestamp":1777255905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eugenol mitigates schizophrenia-like behavioral deficits, oxidative stress, apoptosis, neuroinflammation, and cholinergic dysfunction in ketamine-induced mice"],"prefix":"10.1007","volume":"34","author":[{"given":"Rotu Arientare","family":"Rume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mega Obukowo","family":"Oyovwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotu A.","family":"Rotu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benneth","family":"Ben-Azu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esthinsheen","family":"Osirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"603_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40501-024-00324-x","volume":"11","author":"T Reynolds de Sousa","year":"2024","unstructured":"Reynolds de Sousa T, Ribeiro M, Novais F. Assessment of Innovative Pharmacological Targets in Schizophrenia. Curr Treat Options Psychiatry. 2024;11(3):203\u201317.","journal-title":"Curr Treat Options Psychiatry"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1745017901511010158","volume":"11","author":"M Szkultecka-D\u0119bek","year":"2015","unstructured":"Szkultecka-D\u0119bek M, Walczak J, Augusty\u0144ska J, Miernik K, Stelmachowski J, Pieni\u0105\u017cek I, Obrzut G, Pogroszewska A, Pauli\u0107 G, Damir M, Antoli\u0107 S. Epidemiology and treatment guidelines of negative symptoms in schizo-phrenia in central and eastern Europe: a literature review. Clin Pract Epidemiol mental health: CP EMH. 2015;11:158.","journal-title":"Clin Pract Epidemiol mental health: CP EMH"},{"key":"603_CR3","doi-asserted-by":"crossref","unstructured":"Jarab A, Al-Qerem W, Khdour A, Awadallah H, Mimi Y, Khdour M. Novel pharmaceutical treatment approaches for schizophrenia: a systematic literature review. Eur J Clin Pharmacol 2025;14:1\u20137.","DOI":"10.1007\/s00228-025-03809-7"},{"issue":"3","key":"603_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1192\/bjp.2024.195","volume":"226","author":"J Hall","year":"2025","unstructured":"Hall J. Schizophrenia\u2013new treatments soon. Br J Psychiatry. 2025;226(3):127\u20138.","journal-title":"Br J Psychiatry"},{"key":"603_CR5","first-page":"1","volume":"13","author":"A Anwar","year":"2025","unstructured":"Anwar A, Mustafa AM, Abdou K, Rabie A, El-Shiekh M, El-Dessouki RA. A comprehensive review on schizophrenia: epidemiology, pathogenesis, diagnosis, conventional treatments, and proposed natural compounds used for management. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology. Jun. 2025;13:1\u201325.","journal-title":"Jun"},{"issue":"1","key":"603_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41537-024-00468-y","volume":"10","author":"H Yang","year":"2024","unstructured":"Yang H, Sun W, Yang M, Li J, Zhang J, Zhang X. Variations to plasma H2O2 levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology. Schizophrenia. 2024;10(1):45.","journal-title":"Schizophrenia"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"1505397","DOI":"10.3389\/fpsyt.2025.1505397","volume":"16","author":"K Zhang","year":"2025","unstructured":"Zhang K, Zou L, Cai Y. Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities. Front Psychiatry. 2025;16:1505397.","journal-title":"Front Psychiatry"},{"issue":"1","key":"603_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41398-023-02570-8","volume":"13","author":"SE Herniman","year":"2023","unstructured":"Herniman SE, Wood SJ, Khandaker G, Dazzan P, Pariante CM, Barnes NM, Krynicki CR, Nikkheslat N, Vincent RC, Roberts A, Giordano A. Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial. Translational psychiatry. 2023;13(1):297.","journal-title":"Translational psychiatry"},{"issue":"15","key":"603_CR9","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.3390\/ijms25158477","volume":"25","author":"H Lv","year":"2024","unstructured":"Lv H, Guo M, Guo C, He K. The interrelationships between cytokines and schizophrenia: a systematic review. Int J Mol Sci. 2024;25(15):8477.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"603_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","volume":"15","author":"UC Dash","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, et al. Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B. 2025;15(1):15\u201334.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"603_CR11","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3390\/antiox11112275","volume":"11","author":"C Mor\u00e9n","year":"2022","unstructured":"Mor\u00e9n C, Treder N, Mart\u00ednez-Pinte\u00f1o A, Rodr\u00edguez N, Arbelo N, Madero S, G\u00f3mez M, Mas S, Gass\u00f3 P, Parellada E. Systematic review of the therapeutic role of apoptotic inhibitors in neurodegeneration and their potential use in schizophrenia. Antioxidants. 2022;11(11):2275.","journal-title":"Antioxidants"},{"key":"603_CR12","first-page":"1","volume":"20","author":"Z Saint-Georges","year":"2025","unstructured":"Saint-Georges Z, MacDonald J, Al-Khalili R, Hamati R, Solmi M, Keshavan MS, Tuominen L, Guimond S. Cholinergic system in schizophrenia: A systematic review and meta-analysis. Mol Psychiatry. 2025;20:1\u20135.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"603_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41537-024-00472-2","volume":"10","author":"CN Metz","year":"2024","unstructured":"Metz CN, Brines M, Pavlov VA. Bridging cholinergic signalling and inflammation in schizophrenia. Schizophrenia. 2024;10(1):51.","journal-title":"Schizophrenia"},{"key":"603_CR14","first-page":"1","volume":"2","author":"A Shaju","year":"2025","unstructured":"Shaju A, Mishra A, Mohapatra D, Srinivasan A, Maiti R. Efficacy and safety of cholinergic modulators in patients with schizophrenia: meta-analysis of randomised controlled trials. Br J Psychiatry. 2025;2:1\u20131.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"603_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2174\/1570159X19666210215121428","volume":"20","author":"R Benvenutti","year":"2022","unstructured":"Benvenutti R, Gallas-Lopes M, Marcon M, Reschke CR, Herrmann AP, Piato A. Glutamate NMDA receptor antagonists with relevance to schizophrenia: a review of zebrafish behavioral studies. Curr Neuropharmacol. 2022;20(3):494\u2013509.","journal-title":"Curr Neuropharmacol"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ibneur.2023.12.012","volume":"16","author":"AH Moghaddam","year":"2024","unstructured":"Moghaddam AH, Estalkhi FM, Jelodar SK, Hasan TA, Farhadi-Pahnedari S, Karimian M. Neuroprotective effects of alpha-pinene against behavioral deficits in ketamine-induced mice model of schizophrenia: focusing on oxidative stress status. IBRO Neurosci Rep. 2024;16:182\u20139.","journal-title":"IBRO Neurosci Rep"},{"key":"603_CR17","doi-asserted-by":"crossref","unstructured":"Phensy A, Driskill C, Lindquist K, Guo L, Jeevakumar V, Fowler B, Du H, Kroener S. Antioxidant treatment in male mice prevents mitochondrial and synaptic changes in an NMDA receptor dysfunction model of schizophrenia. ENeuro. 2017;4(4).","DOI":"10.1523\/ENEURO.0081-17.2017"},{"issue":"1","key":"603_CR18","first-page":"1","volume":"20","author":"CI Uruaka","year":"2025","unstructured":"Uruaka CI, Ben-Azu B, Omeiza NA, Chidebe EO, Ajayi AM, Lemii CB, Nonju TI, Georgewill UO, Georgewill OA. Inhibition of oxidative stress, neuroinflammatory cytokines, and protein expressions contributes to the antipsychotic effects of geraniol in mice with ketamine-induced schizophrenia. J Neuroimmune Pharmacol. 2025;20(1):1\u201323.","journal-title":"J Neuroimmune Pharmacol"},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.brainresbull.2021.10.007","volume":"177","author":"IO Ishola","year":"2021","unstructured":"Ishola IO, Ben-Azu B, Adebayo OA, Ajayi AM, Omorodion IL, Edje KE, et al. Prevention and reversal of ketamine-induced experimental psychosis in mice by the neuroactive flavonoid, hesperidin: the role of oxidative and cholinergic mechanisms. Brain Res Bull. 2021;177:239\u201351.","journal-title":"Brain Res Bull"},{"key":"603_CR20","first-page":"187","volume":"29","author":"B Saxena","year":"2024","unstructured":"Saxena B. Eugenol as Neuro-Phytomedicine: Recent Trends Pertaining to the Treatment of Neurological Disorders. NeuroPhytomedicine. Jan. 2024;29:187\u2013204.","journal-title":"Jan"},{"issue":"4","key":"603_CR21","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1007\/s12668-024-01568-w","volume":"14","author":"NS Tripathy","year":"2024","unstructured":"Tripathy NS, Sahoo L, Paikray SK, Dilnawaz F. Eugenol: the phytocompound\u2019s potential biological applications. BioNanoScience. 2024;14(4):4044\u201355.","journal-title":"BioNanoScience"},{"issue":"02","key":"603_CR22","first-page":"8","volume":"12","author":"N Parween","year":"2021","unstructured":"Parween N, Jabeen A, Prasad B. Eugenol-a review of a versatile molecule with remarkable pharmacological properties. J Adv Sci Res. 2021;12(02):8\u201312.","journal-title":"J Adv Sci Res"},{"issue":"1","key":"603_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3957262","volume":"2018","author":"JN Barboza","year":"2018","unstructured":"Barboza JN, da Silva Maia Bezerra Filho C, Silva RO, Medeiros JV, de Sousa DP. An overview on the anti-inflammatory potential and antioxidant profile of eugenol. Oxid Med Cell Longev. 2018;2018(1):3957262.","journal-title":"Oxid Med Cell Longev"},{"key":"603_CR24","doi-asserted-by":"crossref","unstructured":"Kakkar A, Singh H, Anand A, Chopra H, Mishra AK. Neuroprotective Effects of Eugenol in Alzheimer\u2019s Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques. Curr Pharm Design. 2025.","DOI":"10.2174\/0113816128373290250620054118"},{"issue":"1","key":"603_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1573407210602010057","volume":"2","author":"Y Irie","year":"2006","unstructured":"Irie Y. Effects of eugenol on the central nervous system: its possible application to treatment of Alzheimer\u2019s disease, depression, and Parkinson\u2019s disease. Curr Bioact Compd. 2006;2(1):57\u201366.","journal-title":"Curr Bioact Compd"},{"issue":"3","key":"603_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/biom15030452","volume":"15","author":"T Sargsyan","year":"2025","unstructured":"Sargsyan T, Simonyan HM, Stepanyan L, Tsaturyan A, Vicidomini C, Pastore R, Guerra G, Roviello GN. Neuroprotective Properties of Clove (Syzygium aromaticum): State of the Art and Future Pharmaceutical Applications for Alzheimer\u2019s Disease. Biomolecules. 2025;15(3):452.","journal-title":"Biomolecules"},{"issue":"4","key":"603_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5582\/ddt.2022.01026","volume":"16","author":"U Vora","year":"2022","unstructured":"Vora U, Vyas VK, Wal P, Saxena B. Effects of eugenol on the behavioral and pathological progression in the MPTP-induced Parkinson\u2019s disease mouse model. Drug Discov Ther. 2022;16(4):154\u201363.","journal-title":"Drug Discov Ther"},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"1280608","DOI":"10.3389\/fnbeh.2023.1280608","volume":"17","author":"P Horka","year":"2024","unstructured":"Horka P, Langova V, Hubeny J, Vales K, Chrtkova I, Horacek J. Open field test for the assessment of anxiety-like behavior in Gnathonemus petersii fish. Front Behav Neurosci. 2024;17:1280608.","journal-title":"Front Behav Neurosci"},{"key":"603_CR29","doi-asserted-by":"publisher","first-page":"112022","DOI":"10.1016\/j.biopha.2021.112022","volume":"142","author":"MO Oyovwi","year":"2021","unstructured":"Oyovwi MO, Ben-Azu B, Edesiri TP, Victor E, Rotu RA, Ozegbe QE, Nwangwa EK, Atuadu V, Adebayo OG. Kolaviron abates busulfan-induced episodic memory deficit and testicular dysfunction in rats: the implications for neuroendopathobiological changes during chemotherapy. Biomed Pharmacother. 2021;142:112022.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"603_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5607\/en.2019.28.2.247","volume":"28","author":"DG Kim","year":"2019","unstructured":"Kim DG, Gonzales EL, Kim S, Kim Y, Adil KJ, Jeon SJ, et al. Social interaction test in home cage as a novel and ethological measure of social behavior in mice. Exp Neurobiol. 2019;28(2):247.","journal-title":"Exp Neurobiol"},{"issue":"1","key":"603_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2021.102008","volume":"117","author":"M Hassanzadeh-Taheri","year":"2021","unstructured":"Hassanzadeh-Taheri M, Ahmadi-Zohan A, Mohammadifard M, Hosseini M. Rosmarinic acid attenuates lipopolysaccharide-induced neuroinflammation and cognitive impairment in rats. J Chem Neuroanat. 2021;117(1):102008.","journal-title":"J Chem Neuroanat"},{"issue":"10","key":"603_CR32","first-page":"3079","volume":"28","author":"CC Onyekweli","year":"2024","unstructured":"Onyekweli CC, Ben-Azu B, Nwangwa EK, Oyovwi OM. Potential effects of epigallocatechin-gallate against high-fat diet-induced memory decline andtesticular abnormalities in male wistar rats. J Appl Sci Environ Manage. 2024;28(10):3079\u201395.","journal-title":"J Appl Sci Environ Manage"},{"issue":"4","key":"603_CR33","doi-asserted-by":"publisher","first-page":"e14071","DOI":"10.1111\/jfbc.14071","volume":"46","author":"EP Tesi","year":"2022","unstructured":"Tesi EP, Ben-Azu B, Mega OO, Mordi J, Knowledge OO, Awele ED, Rotu RA, Emojevwe V, Adebayo OG, Eneni OA. Kolaviron, a flavonoid\u2010rich extract ameliorates busulfan\u2010induced chemo\u2010brain and testicular damage in male rats through inhibition of oxidative stress, inflammatory, and apoptotic pathways. J Food Biochem. 2022;46(4):e14071.","journal-title":"J Food Biochem"},{"issue":"2","key":"603_CR34","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00210-023-02637-9","volume":"397","author":"MO Oyovwi","year":"2024","unstructured":"Oyovwi MO, Ben-Azu B, Falajiki FY, Onome OB, Rotu RA, Rotu RA, Oyeleke AA, Okwute GP, Moke EG. D-ribose-L-cysteine exhibits restorative neurobehavioral functions through modulation of neurochemical activities and inhibition oxido-inflammatory perturbations in rats exposed to polychlorinated biphenyl. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(2):931\u201345.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"603_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100243","volume":"13","author":"MO Oyovwi","year":"2025","unstructured":"Oyovwi MO, Ugwuishi EW, Udi OA, Atere AD, Rotu AR, Odokuma EI, et al. Epigallocatechin-gallate ameliorates polystyrene microplastics-induced oxido-inflammation and mitochondria-mediated apoptosis in testicular cells via modulation of Nrf2\/HO-1,\/mTOR\/Atg-7, and Cx-43\/NOX-1 levels. European Journal of Medicinal Chemistry Reports. 2025;13(1):100243.","journal-title":"European Journal of Medicinal Chemistry Reports"},{"issue":"4","key":"603_CR36","doi-asserted-by":"publisher","first-page":"200178","DOI":"10.1016\/j.ctmp.2024.200178","volume":"5","author":"MO Oyovwi","year":"2024","unstructured":"Oyovwi MO, Rotu AR, Emojevwe VO, Adeogun AE, Udi OA. Investigating the protective effects of epigallocatechin-gallate against polystyrene microplastics-induced biochemical and hematological alterations in rats. Clin Traditional Med Pharmacol. 2024;5(4):200178.","journal-title":"Clin Traditional Med Pharmacol"},{"issue":"1","key":"603_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pestbp.2021.104833","volume":"175","author":"MO Oyovwi","year":"2021","unstructured":"Oyovwi MO, Ben-Azu B, Tesi EP, Oyeleke AA, Uruaka CI, Rotu RA, et al. Repeated endosulfan exposure induces changes in neurochemicals, decreases ATPase transmembrane ionic-pumps, and increased oxidative\/nitrosative stress in the brains of rats: reversal by quercetin. Pestic Biochem Physiol. 2021;175(1):104833.","journal-title":"Pestic Biochem Physiol"},{"issue":"2","key":"603_CR38","doi-asserted-by":"publisher","first-page":"20180038","DOI":"10.1515\/jcim-2018-0038","volume":"16","author":"NC Ximenes","year":"2019","unstructured":"Ximenes NC, Dos Santos J\u00fanior MA, Vasconcelos GS, Dias KC, Juc\u00e1 MM, Silva AH, Leal LK, Viana GS, de Sousa FC, Vasconcelos SM. Ethanolic extract of Erythrina velutina Willd ameliorate schizophrenia-like behavior induced by ketamine in mice. J Complement Integr Med. 2019;16(2):20180038.","journal-title":"J Complement Integr Med"},{"key":"603_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ibneur.2023.12.008","volume":"16","author":"B Ben-Azu","year":"2024","unstructured":"Ben-Azu B, Adebayo OG, Fokoua AR, Oritsemuelebi B, Chidebe EO, Nwogueze CB, et al. Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: involvement of oxidative stress and cholinergic transmission. IBRO Neurosci Rep. 2024;16:86\u201397.","journal-title":"IBRO Neurosci Rep"},{"issue":"4","key":"603_CR40","doi-asserted-by":"publisher","first-page":"155932582412916","DOI":"10.1177\/15593258241291652","volume":"22","author":"A Chongtham","year":"2024","unstructured":"Chongtham A, Agrawal N. Neuroprotective Potential of Eugenol in Polyglutamine-Mediated Neurodegenerative Disease Using Transgenic Drosophila Model. Dose-Response. 2024;22(4):15593258241291652.","journal-title":"Dose-Response"},{"issue":"4","key":"603_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jtcme.2021.01.003","volume":"11","author":"J Barot","year":"2021","unstructured":"Barot J, Saxena B. Therapeutic effects of eugenol in a rat model of traumatic brain injury: a behavioral, biochemical, and histological study. J Tradit Complement Med. 2021;11(4):318\u201327.","journal-title":"J Tradit Complement Med"},{"issue":"1","key":"603_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8881770","volume":"2021","author":"EA Ermakov","year":"2021","unstructured":"Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev. 2021;2021(1):8881770.","journal-title":"Oxid Med Cell Longev"},{"key":"603_CR43","doi-asserted-by":"publisher","first-page":"590088","DOI":"10.3389\/fnins.2020.590088","volume":"14","author":"M Bove","year":"2020","unstructured":"Bove M, Tucci P, Dimonte S, Trabace L, Schiavone S, Morgese MG. Postnatal antioxidant and anti-inflammatory treatments prevent early ketamine-induced cortical dysfunctions in adult mice. Front NeuroSci. 2020;14:590088.","journal-title":"Front NeuroSci"},{"issue":"1","key":"603_CR44","volume":"2020","author":"SB Mesole","year":"2020","unstructured":"Mesole SB, Alfred OO, Yusuf UA, Lukubi L, Ndhlovu D. Apoptotic inducement of neuronal cells by aluminium chloride and the neuroprotective effect of eugenol in wistar rats. Oxid Med Cell Longev. 2020;2020(1):8425643.","journal-title":"Oxid Med Cell Longev"},{"key":"603_CR45","doi-asserted-by":"publisher","first-page":"111253","DOI":"10.1016\/j.brainresbull.2025.111253","volume":"10","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Tian M, Lu S, Qin Y, Zhao T, Shi H, Li Z, Qin D. The antioxidant role of aromatic plant extracts in managing neurodegenerative diseases: A comprehensive review. Brain Res Bull. 2025;10:111253.","journal-title":"Brain Res Bull."},{"issue":"8","key":"603_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.70727","volume":"13","author":"AM Noman","year":"2025","unstructured":"Noman AM, Sultan MT, Mazhar A, Khan WA, Imran M, Hussain M, et al. Eugenol: an insight into the anticancer perspective and pharmacological aspects. Food Sci Nutr. 2025;13(8):e70727.","journal-title":"Food Sci Nutr"},{"issue":"11","key":"603_CR47","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ph17111505","volume":"17","author":"RO Damasceno","year":"2024","unstructured":"Damasceno RO, Pinheiro JL, Rodrigues LH, Gomes RC, Duarte AB, Em\u00eddio JJ, Diniz LR, de Sousa DP. Anti-inflammatory and antioxidant activities of eugenol: An update. Pharmaceuticals. 2024;17(11):1505.","journal-title":"Pharmaceuticals"},{"issue":"7","key":"603_CR48","doi-asserted-by":"publisher","first-page":"27636","DOI":"10.31083\/JIN27636","volume":"24","author":"E Ermakov","year":"2025","unstructured":"Ermakov E, Mednova I, Boiko A, Ivanova S. Neuroinflammation in Schizophrenia: An Overview of Evidence and Implications for Pathophysiology. J Integr Neurosci. 2025;24(7):27636.","journal-title":"J Integr Neurosci"},{"key":"603_CR49","doi-asserted-by":"publisher","first-page":"536257","DOI":"10.3389\/fpsyt.2021.536257","volume":"12","author":"M Reale","year":"2021","unstructured":"Reale M, Costantini E, Greig NH. Cytokine imbalance in schizophrenia. From research to clinic: potential implications for treatment. Front Psychiatry. 2021;12:536257.","journal-title":"Front Psychiatry"},{"issue":"4","key":"603_CR50","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/japplphysiol.00560.2009","volume":"108","author":"CB Magalh\u00e3es","year":"2010","unstructured":"Magalh\u00e3es CB, Riva DR, DePaula LJ, Brando-Lima A, Koatz VL, Leal-Cardoso JH, Zin WA, Faffe DS. In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J Appl Physiol. 2010;108(4):845\u201351.","journal-title":"J Appl Physiol"},{"issue":"6","key":"603_CR51","first-page":"7648","volume":"9","author":"PANK Permatananda","year":"2025","unstructured":"Permatananda PANK, Yasa IWPS, Sumardika IW, Saraswati MR, Pandit IGS. From tradition to translation: a systematic review on the pharmacological actions of eugenol extracted from Ocimum plants in oxidative stress, inflammation, and diabetes mellitus. Bioscientia Medicina: J Biomed Translational Res. 2025;9(6):7648\u201363.","journal-title":"Bioscientia Medicina: J Biomed Translational Res"},{"issue":"5","key":"603_CR52","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","volume":"29","author":"LF Jarskog","year":"2005","unstructured":"Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5):846\u201358.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"603_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/adb.70025","volume":"30","author":"S Sabziparvar","year":"2025","unstructured":"Sabziparvar S, Khodaei K, Azar JT. Treadmill exercise training ameliorates apoptotic cells and DNA oxidation in the cerebral cortex of rats exposed to chronic ketamine abuse. Addict Biol. 2025;30(3):e70025.","journal-title":"Addict Biol"},{"issue":"6","key":"603_CR54","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF. Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules. 2022;27(6):1816.","journal-title":"Molecules"},{"issue":"17","key":"603_CR55","doi-asserted-by":"publisher","first-page":"9290","DOI":"10.3390\/ijms22179290","volume":"22","author":"\u0141J Walczak-Nowicka","year":"2021","unstructured":"Walczak-Nowicka \u0141J, Herbet M. Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis. Int J Mol Sci. 2021;22(17):9290.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"603_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/neu.2013.31","volume":"26","author":"AI Zugno","year":"2014","unstructured":"Zugno AI, Matos MP, Canever L, Fraga DB, De Luca RD, Ghedim FV, et al. Evaluation of acetylcholinesterase activity and behavioural alterations induced by ketamine in an animal model of schizophrenia. Acta Neuropsychiatr. 2014;26(1):43\u201350.","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"603_CR57","doi-asserted-by":"publisher","first-page":"e13276","DOI":"10.1111\/jfbc.13276","volume":"45","author":"SA Adefegha","year":"2021","unstructured":"Adefegha SA, Okeke BM, Oboh G. Antioxidant properties of eugenol, butylated hydroxylanisole, and butylated hydroxyl toluene with key biomolecules relevant to Alzheimer\u2019s diseases\u2014in vitro. J Food Biochem. 2021;45(3):e13276.","journal-title":"J Food Biochem"},{"key":"603_CR58","doi-asserted-by":"publisher","first-page":"154930","DOI":"10.1016\/j.phymed.2023.154930","volume":"118","author":"MJ Jung","year":"2023","unstructured":"Jung MJ, Kim N, Jeon SH, Gee MS, Kim JW, Lee JK. Eugenol relieves the pathological manifestations of Alzheimer\u2019s disease in 5\u00d7 FAD mice. Phytomedicine. 2023;118:154930.","journal-title":"Phytomedicine"},{"issue":"1","key":"603_CR59","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41380-021-01092-3","volume":"27","author":"Z Yan","year":"2022","unstructured":"Yan Z, Rein B. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications. Mol Psychiatry. 2022;27(1):445\u201365.","journal-title":"Mol Psychiatry"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00603-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T16:02:25Z","timestamp":1780156945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00603-3","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Each author approved the publication of the paper with their signature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}